SMTL ID : 3byu.1

co-crystal structure of Lck and aminopyrimidine reverse amide 23

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x AM6: 2-methyl-N-{4-methyl-3-[(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-5-yl)carbamoyl]phenyl}-3-(trifluoromethyl)benzamide(Non-covalent)

AM6.1: 21 residues within 4Å: Chain A: L.27, A.47, V.48, K.49, E.64, M.68, L.71, L.76, V.77, I.90, T.92, E.93, Y.94, M.95, G.98, Y.136, L.147, I.156, A.157, D.158, F.159 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.27, A:A.47, A:E.64, A:V.77, A:I.90, A:T.92, A:Y.94, A:L.147, A:D.158 Hydrogen bonds: A:E.64, A:T.92, A:M.95, A:M.95, A:D.158

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

DiMauro, E.F. et al., Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation. J.Med.Chem. (2008)

Release Date

2008-09-16

Peptides

Proto-oncogene tyrosine-protein kinase LCK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Proto-oncogene tyrosine-protein kinase LCK

Related Entries With Identical Sequence